Experts decry FDA’s halting of a high-profile Covid-19 study over approvals

Regulators at the Food and Drug Administration told STAT the agency’s decision this month to halt a high-profile, Bill Gates-backed effort to study the spread of coronavirus in the Seattle area came after the researchers involved failed to secure needed approval.